Tech Company Financing Transactions

Vitae Pharmaceuticals Funding Round

On 12/31/2007, Vitae Pharmaceuticals announced $15 million in funding from Atlas Venture, New Enterprise Associates and Prospect Venture Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

502 West Office Center Dr.
Fort Washington, PA 19034
USA

Phone

(215) 461-2000

Website

www.vitaepharma.com

Email Address

[email protected]

Overview

Vitae Pharmaceuticals (NADAQ: VTAE) is developing a robust and growing portfolio of novel product candidates generated by Contour, our proprietary computationally-based SBDD platform.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeffrey Hatfield

        

Chief Financial Officer

Richard Morris

        

Chief Medical Officer

Carole Sable

        

Chief Scientific Officer

Richard Gregg

        

VP - Bus. Development

Arthur Fratamico

        

Browse more venture capital transactions:

Prev: 12/31/2007: Serious.com venture capital transaction
Next: 12/31/2007: AutekBio venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary